• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation.益生菌传递的进展综述:用于肠道菌群补充的常规与非常规制剂。
AAPS PharmSciTech. 2014 Feb;15(1):29-43. doi: 10.1208/s12249-013-0027-1. Epub 2013 Sep 25.
2
Efficient protection of microorganisms for delivery to the intestinal tract by cellulose sulphate encapsulation.通过纤维素硫酸酯包封实现对微生物的有效保护,以便递送至肠道。
Microb Cell Fact. 2020 Nov 26;19(1):216. doi: 10.1186/s12934-020-01465-3.
3
A gastro-resistant ovalbumin bi-layered mini-tablet-in-tablet system for the delivery of Lactobacillus acidophilus probiotic to simulated human intestinal and colon conditions.一种用于将嗜酸乳杆菌益生菌递送至模拟人体肠道和结肠环境的胃内滞留型双层片包片系统。
J Pharm Pharmacol. 2015 Jul;67(7):939-50. doi: 10.1111/jphp.12389. Epub 2015 Feb 2.
4
Insights on the Critical Parameters Affecting the Probiotic Viability During Stabilization Process and Formulation Development.关于影响益生菌在稳定化过程和配方开发过程中存活的关键参数的见解。
AAPS PharmSciTech. 2021 May 18;22(5):156. doi: 10.1208/s12249-021-02024-8.
5
Design of probiotic delivery systems and their therapeutic effects on targeted tissues.益生菌递送系统的设计及其对靶向组织的治疗效果。
J Control Release. 2024 Nov;375:20-46. doi: 10.1016/j.jconrel.2024.08.037. Epub 2024 Sep 4.
6
Targeted delivery of probiotics to enhance gastrointestinal stability and intestinal colonisation.益生菌的靶向递送以增强胃肠道稳定性和肠道定植。
Int J Pharm. 2017 Sep 15;530(1-2):224-229. doi: 10.1016/j.ijpharm.2017.07.068. Epub 2017 Jul 29.
7
Natural sources and encapsulating materials for probiotics delivery systems: Recent applications and challenges in functional food development.用于益生菌递送系统的天然来源和封装材料:功能食品开发中的最新应用与挑战
Front Nutr. 2022 Sep 21;9:971784. doi: 10.3389/fnut.2022.971784. eCollection 2022.
8
Drying techniques of probiotic bacteria as an important step towards the development of novel pharmabiotics.益生菌干燥技术是新型药物益生菌开发的重要一步。
Int J Pharm. 2016 May 30;505(1-2):303-18. doi: 10.1016/j.ijpharm.2016.04.002. Epub 2016 Apr 2.
9
Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent.开发微胶囊递释系统用于益生菌的长期保存作为生物治疗剂。
Biomed Res Int. 2013;2013:620719. doi: 10.1155/2013/620719. Epub 2013 Aug 21.
10
Single-cell encapsulation systems for probiotic delivery: Armor probiotics.单细胞包封系统用于益生菌递送: Armor 益生菌。
Adv Colloid Interface Sci. 2024 Oct;332:103270. doi: 10.1016/j.cis.2024.103270. Epub 2024 Aug 6.

引用本文的文献

1
A Review of Next-Generation Probiotics-As a Gateway to Biotherapeutics.下一代益生菌——通向生物疗法的途径综述
Probiotics Antimicrob Proteins. 2025 Jun 3. doi: 10.1007/s12602-025-10606-2.
2
The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development.肠道微生物群作为癌症免疫治疗的靶点:药物开发的机遇与挑战
Nat Rev Drug Discov. 2025 Jun 2. doi: 10.1038/s41573-025-01211-7.
3
Gut Microbiome Interventions: From Dysbiosis to Next-Generation Probiotics (NGPs) for Disease Management.肠道微生物群干预:从生态失调到用于疾病管理的下一代益生菌(NGPs)
Probiotics Antimicrob Proteins. 2025 May 28. doi: 10.1007/s12602-025-10582-7.
4
The vital role of Lactobacillus sp. in vaginal health: Implications for enhanced prophylactic research.乳酸杆菌属在阴道健康中的重要作用:对加强预防性研究的启示。
Probiotics Antimicrob Proteins. 2025 May 22. doi: 10.1007/s12602-025-10574-7.
5
Combined microbiome and metabolomics analysis of yupingfeng san fermented by : insights into probiotic and herbal interactions.对由[具体发酵主体]发酵的玉屏风散进行微生物组和代谢组学联合分析:探究益生菌与草药的相互作用
PeerJ. 2025 Apr 7;13:e19206. doi: 10.7717/peerj.19206. eCollection 2025.
6
Emulsifier-modified sunflower oil-sunflower wax oleogel as growth modulator of probiotics.乳化剂改性葵花籽油-葵花籽蜡油凝胶作为益生菌的生长调节剂。
BBA Adv. 2025 Feb 8;7:100147. doi: 10.1016/j.bbadva.2025.100147. eCollection 2025.
7
Characterization of Probiotic Strains and and Their Effect on Broiler Chicken Performance and Immune Response During Infection.益生菌菌株的特性及其在感染期间对肉鸡生长性能和免疫反应的影响。
Microorganisms. 2025 Jan 21;13(2):217. doi: 10.3390/microorganisms13020217.
8
The effect of probiotics, prebiotics and synbiotics on gut microbial community profile in overweight and obese Latin American and Caribbean populations: a systematic review of human trials.益生菌、益生元及合生元对拉丁美洲和加勒比地区超重及肥胖人群肠道微生物群落特征的影响:人体试验的系统评价
Gut Microbiome (Camb). 2025 Jan 17;6:e2. doi: 10.1017/gmb.2024.12. eCollection 2025.
9
Pharmacists' Knowledge, Perception, and Prescribing Practice of Probiotics in the UAE: A Cross-Sectional Study.阿联酋药剂师对益生菌的知识、认知及处方实践:一项横断面研究。
Antibiotics (Basel). 2024 Oct 13;13(10):967. doi: 10.3390/antibiotics13100967.
10
Safety Evaluation and antioxidant potential of new probiotic strain (NMCC-path-14) in Balb/c mice by sub-acute repeated dose toxicity.通过亚急性重复剂量毒性试验对新益生菌菌株(NMCC-path-14)在Balb/c小鼠中的安全性评估及抗氧化潜力
Heliyon. 2024 Sep 27;10(19):e38581. doi: 10.1016/j.heliyon.2024.e38581. eCollection 2024 Oct 15.

本文引用的文献

1
The first dairy product exclusively fermented by Propionibacterium freudenreichii: a new vector to study probiotic potentialities in vivo.首个人乳双歧杆菌专属发酵乳制品:一种体内研究益生菌潜力的新载体。
Food Microbiol. 2012 Oct;32(1):135-46. doi: 10.1016/j.fm.2012.05.003. Epub 2012 May 19.
2
Science and technology for the mastership of probiotic applications in food products.科学和技术在掌握益生菌在食品产品中的应用。
J Biotechnol. 2012 Dec 31;162(4):356-65. doi: 10.1016/j.jbiotec.2012.07.006. Epub 2012 Jul 22.
3
Microencapsulation of probiotics for gastrointestinal delivery.益生菌的胃肠道递送的微胶囊化。
J Control Release. 2012 Aug 20;162(1):56-67. doi: 10.1016/j.jconrel.2012.06.003. Epub 2012 Jun 11.
4
Water activity in dry foods containing live probiotic bacteria should be carefully considered: a case study with Lactobacillus rhamnosus GG in flaxseed.在含有活性益生菌的干燥食品中,水活度应仔细考虑:以鼠李糖乳杆菌 GG 在亚麻籽中的应用为例。
Int J Food Microbiol. 2012 Jul 2;157(2):319-21. doi: 10.1016/j.ijfoodmicro.2012.05.016. Epub 2012 May 22.
5
An in vitro evaluation of the effect of probiotics and prebiotics on the metabolic profile of human microbiota.体外评价益生菌和益生元对人体微生物群代谢谱的影响。
Anaerobe. 2012 Aug;18(4):386-91. doi: 10.1016/j.anaerobe.2012.04.014. Epub 2012 May 8.
6
Pilot-scale production and viability analysis of freeze-dried probiotic bacteria using different protective agents.采用不同保护剂的益生菌菌粉的中试规模生产和生存能力分析。
Nutrients. 2010 Mar;2(3):330-9. doi: 10.3390/nu2030330. Epub 2010 Mar 11.
7
In vitro testing of commercial and potential probiotic lactic acid bacteria.商业和潜在益生菌乳酸菌的体外测试。
Int J Food Microbiol. 2012 Feb 1;153(1-2):216-22. doi: 10.1016/j.ijfoodmicro.2011.11.020. Epub 2011 Dec 1.
8
Isolation and characterization of probiotic strains for improving oral health.用于改善口腔健康的益生菌菌株的分离与特性分析。
Arch Oral Biol. 2012 May;57(5):539-49. doi: 10.1016/j.archoralbio.2011.10.006. Epub 2011 Nov 3.
9
The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany.围产期益生菌干预对肠道微生物群的影响:芬兰和德国的双盲安慰剂对照试验。
Anaerobe. 2012 Feb;18(1):7-13. doi: 10.1016/j.anaerobe.2011.09.006. Epub 2011 Sep 29.
10
Combined influence of fermentation and drying conditions on survival and metabolic activity of starter and probiotic cultures after low-temperature vacuum drying.低温真空干燥后发酵和干燥条件对发酵剂和益生菌培养物存活和代谢活性的综合影响。
J Biotechnol. 2012 Jun 30;159(4):351-7. doi: 10.1016/j.jbiotec.2011.06.010. Epub 2011 Jun 23.

益生菌传递的进展综述:用于肠道菌群补充的常规与非常规制剂。

A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation.

机构信息

Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, 2193, Johannesburg, South Africa.

出版信息

AAPS PharmSciTech. 2014 Feb;15(1):29-43. doi: 10.1208/s12249-013-0027-1. Epub 2013 Sep 25.

DOI:10.1208/s12249-013-0027-1
PMID:24222267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3909163/
Abstract

Probiotic delivery systems are widely used nutraceutical products for the supplementation of natural intestinal flora. These delivery systems vary greatly in effectiveness to exert health benefits for a patient. Probiotic delivery systems can be categorized into conventional, pharmaceutical formulations, and non-conventional, mainly commercial food-based, products. The degree of health benefits provided by these probiotic formulations varies in their ability to deliver viable, functional bacteria in large enough numbers (effectiveness), to provide protection against the harsh effects of the gastric environment and intestinal bile (in vivo protection), and to survive formulation processes (viability). This review discusses the effectiveness of these probiotic delivery systems to deliver viable functional bacteria focusing on the ability to protect the encapsulated probiotics during formulation process as well as against harsh physiological conditions through formulation enhancements using coatings and polymer enhancements. A brief overview on the health benefits of probiotics, current formulation, patient and legal issues facing probiotic delivery, and possible recommendations for the enhanced delivery of probiotic bacteria are also provided. Newer advanced in vitro analyses that can accurately determine the effectiveness of a probiotic formulation are also discussed with an ideal probiotic delivery system hypothesized through a combination of the two probiotic delivery systems described.

摘要

益生菌输送系统是广泛用于补充天然肠道菌群的营养保健品。这些输送系统在发挥对患者健康益处的有效性上有很大的差异。益生菌输送系统可分为传统的药物制剂和非传统的,主要是商业的基于食品的产品。这些益生菌配方提供的健康益处程度因它们能够以足够大的数量输送活菌和功能性细菌的能力而有所不同(有效性),提供对胃环境和肠道胆汁的苛刻影响的保护(体内保护),并在制剂过程中存活(生存能力)。本文综述了这些益生菌输送系统输送活菌和功能性细菌的有效性,重点讨论了在制剂过程中保护包封益生菌的能力,以及通过使用涂层和聚合物增强来改善制剂,抵抗苛刻生理条件的能力。还简要概述了益生菌的健康益处、当前的配方、益生菌输送面临的患者和法律问题,以及对益生菌细菌增强输送的可能建议。还讨论了新的更先进的体外分析方法,这些方法可以准确确定益生菌配方的有效性,并通过结合描述的两种益生菌输送系统来假设理想的益生菌输送系统。